Eagle Pharmaceuticals, Inc.
(NASDAQ: EGRX)
Settlement
Claim Deadline: October 16, 2026 (42 Days Left)
Settlement Fund: $9,500,000
Settlement Class
All persons or entities that purchased the publicly traded common stock of Eagle Pharmaceuticals, Inc. between August 9, 2022 and October 1, 2024, both dates inclusive.
Settlement Status
Final Approval
Class Period
August 9, 2022 - December 30, 2024
Hearing Date
August 19, 2026
Claim Deadline
October 16, 2026
Levi & Korsinsky, LLP did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.